Clinical Trial Update: A Multiple Dose Study of MK-3614 (MK-3614-002) [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose trial of MK-3614 completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK-3614

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2021-05-03